USP25 inhibition ameliorates Alzheimer’s pathology through the regulation of APP processing and Aβ generation
暂无分享,去创建一个
H. Qing | Xiuzhen Zhang | Timothy Y. Huang | Y. Zhang | Weihong Song | Yili Wu | Yingjun Zhao | C. Dong | Xian Zhang | Qiuyang Zheng | Fang Cai | Lishan Zhang | Meiling Wu | Lu-Lin Jiang | Huan Hou | Xin Wang | Ying Zhou | Tiantian Guo | Hong Luo | Hongfeng Zhang | Huaxi Xu | Zhiping Zeng | Qing Zhang | Fanwei Zeng | Beibei Song | Yi-Ran Zhao | Xu Wang | Anjie Di | Guilin Li | Mingyu Shen
[1] Meng Chen,et al. Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases , 2021, Molecular Psychiatry.
[2] B. Tycko,et al. Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome , 2021, Frontiers in Aging Neuroscience.
[3] Huaxi Xu,et al. Trisomy 21–induced dysregulation of microglial homeostasis in Alzheimer’s brains is mediated by USP25 , 2021, Science Advances.
[4] P. Worley,et al. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome , 2020, Molecular Neurodegeneration.
[5] G. Šimić,et al. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue , 2020, Molecular Neurodegeneration.
[6] Huaxi Xu,et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease , 2020, Molecular Neurodegeneration.
[7] J. Dudley,et al. miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease , 2020, Acta Neuropathologica.
[8] C. Kisker,et al. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities. , 2019, Molecular cell.
[9] Weihong Song,et al. BACE2, a conditional β-secretase, contributes to Alzheimer's disease pathogenesis. , 2019, JCI insight.
[10] Dean Nizetic,et al. Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP , 2018, Brain : a journal of neurology.
[11] J. Boros,et al. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily. , 2017, ACS chemical biology.
[12] M. Wolfe,et al. Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage , 2017, The Journal of Biological Chemistry.
[13] Weihong Song,et al. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis , 2017, The Journal of Neuroscience.
[14] Weihong Song,et al. Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis? , 2017, Progress in Neurobiology.
[15] Huaxi Xu,et al. Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases , 2016, Front. Aging Neurosci..
[16] K. Rhodes,et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.
[17] Richard C. Rice,et al. Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration* , 2016, The Journal of Biological Chemistry.
[18] G. Tesco,et al. The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation* , 2016, The Journal of Biological Chemistry.
[19] J. Hardy,et al. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome☆ , 2014, Neurobiology of Aging.
[20] Weihong Song,et al. Aberrant Expression of RCAN1 in Alzheimer’s Pathogenesis: A New Molecular Mechanism and a Novel Drug Target , 2014, Molecular Neurobiology.
[21] P. McCallion,et al. A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome. , 2014, Journal of intellectual disability research : JIDR.
[22] Ayae Kinoshita,et al. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. , 2013, The Journal of clinical investigation.
[23] G. Tesco,et al. BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus* , 2012, The Journal of Biological Chemistry.
[24] C. Dong,et al. Negative regulation of IL-17-mediated signaling and inflammation by ubiquitin-specific protease 25 , 2012, Nature Immunology.
[25] J. Barral,et al. Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688 , 2012, Proceedings of the National Academy of Sciences.
[26] Y. Shintani,et al. FBL2 Regulates Amyloid Precursor Protein (APP) Metabolism by Promoting Ubiquitination-Dependent APP Degradation and Inhibition of APP Endocytosis , 2012, The Journal of Neuroscience.
[27] G. Wen,et al. Alzheimer's disease in Down's syndrome: Clinicopathologic studies , 2011, Neurology.
[28] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[29] J. Roder,et al. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice , 2010, Brain Research.
[30] Rudolph E Tanzi,et al. Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid-β Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex , 2010, The Journal of Neuroscience.
[31] Huali Wang,et al. Cognitive function of first-episode late-onset depression among Chinese elderly , 2009, Alzheimer's & Dementia.
[32] D. Bennett,et al. Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis , 2008, Neuron.
[33] Hong Qing,et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.
[34] Hyun-Jeong Cho,et al. Dual‐specificity tyrosine(Y)‐phosphorylation regulated kinase 1A‐mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease , 2008, Journal of neurochemistry.
[35] N. Nowak,et al. Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. , 2007, Human molecular genetics.
[36] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[37] L. Mucke,et al. Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.
[38] Xiulian Sun,et al. BACE2, as a novel APP θ‐secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] H. Qing,et al. Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] M. Tymms,et al. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome. , 2003, Biochimica et biophysica acta.
[41] Yu-Wang Liu,et al. Positive and negative regulation of APP amyloidogenesis by sumoylation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Raskind,et al. Early Amyloid Deposition in the Medial Temporal Lobe of Young Down Syndrome Patients: A Regional Quantitative Analysis , 1998, Experimental Neurology.
[43] P. Greengard,et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides , 1998, Nature Medicine.
[44] P. Greengard,et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. , 1998, Nature medicine.